Barclays
KRRO icon

Barclays’s Korro Bio KRRO Stock Holding History

Barclays’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,241
Closed -$126K – 5413
2025
Q1 		$126K Sell
7,241
-3,143
-30% -$93.2K ﹤0.01% 4306
2024
Q4 		$395K Buy
+10,384
New +$534K ﹤0.01% 3967
2023
Q1 		– Sell
-212
Closed -$40.8K – 5223
2022
Q4 		$40.8K Sell
212
-19
-8% -$1.96K ﹤0.01% 4618
2022
Q3 		$21K Sell
231
-36
-13% -$3.65K ﹤0.01% 4047
2022
Q2 		$20K Sell
267
-103
-28% -$6.96K ﹤0.01% 4403
2022
Q1 		$39K Buy
+370
New +$70.7K ﹤0.01% 4211

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return

Barclays's KRRO Position: Q2 2025 in Review

Barclays sold out of Korro Bio (KRRO) in Q2 2025, closing a stake of 7,241 shares — an estimated $126K sold.

Barclays first reported a position in KRRO in Q1 2022 and held it in 6 quarters. The position peaked at $395K in Q4 2024. 70 funds tracked by Wall St. Rank hold KRRO as of Q2 2025.

  • Barclays reported no remaining Korro Bio position as of Q2 2025 after selling out during the quarter.
  • Barclays sold 7,241 Korro Bio shares in Q2 2025, an estimated $126K.
  • Barclays first reported a position in Korro Bio in Q1 2022 and held it in 6 quarters.
  • Barclays's Korro Bio position peaked at $395K in Q4 2024.
  • 70 funds tracked by Wall St. Rank held Korro Bio as of Q2 2025.

Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.